Skin

Liver Cancer :: Nexavar approved for patients with inoperable liver cancer

Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.

Rheumatoid Arthritis :: Cardiovascular Disease Risk for Rheumatoid Arthritis Patients

People with rheumatoid arthritis have a higher risk for developing heart disease than the general population; however, it is difficult to identify which patients are at increased risk. Researchers at Mayo Clinic have developed a simple approach to predict heart disease in these patients within ten years of their initial diagnosis of rheumatoid arthritis.

Lupus :: Immunosuppressive drug effective for reducing lupus flares

Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus (SLE). SLE results in inflammation of connective tissues and can involve the skin, joints and kidneys. Its cause is unknown. The findings were announced today at the annual meeting of the American College of Rheumatology in Boston.

Lupus :: Existing drugs show promise for treating end-stage renal disease in lupus

Studies in mice suggest that two drugs already approved by the U.S. Food and Drug Administration show promise for treating the complications of lupus, according to Nilamadham Mishra, M.D., in presentations this week at the American College of Rheumatology in Boston.

Antioxidant :: Antioxidants could provide all-purpose radiation protection

Two common dietary molecules found in legumes and bran could protect DNA from the harmful effects of radiation, researchers from the University of Maryland report. Inositol and inositol hexaphosphate (IP6) protected both human skin cells and a skin cancer-prone mouse from exposure to ultraviolet B (UVB) radiation, the damaging radiation found in sunlight, the team reported today at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.

Skin :: Stressed-out skin loses its antimicrobial defense mechanism

It is well known that being stressed increases our susceptibility to infections by impairing the function of our immune system, but the molecular links between stress and diminished immune function have not been determined. However, Peter Elias and colleagues at UCSF, have now characterized a mechanistic link in mice between psychological stress and increased susceptibility to skin infections.

Depression :: Depression and homoeopathy

Homoeopathy is a science of Life. Human beings are liable to various kinds of diseases though the creator has created them to be healthy; but, there are different kinds of circumstances, temptations and pitfalls which affect the human beings on physical as well as on mental levels. The mode living, eating habits, atmospheric change, mental stress and also the telluric effects are the factors singly or in combination which affect the health of individuals.

Cervical Cancer :: Women still face cancer risk 25 years after treatment

Women are still at risk of developing invasive cancer of the cervix or vagina 25 years after being treated for pre-cancerous lesions, according to a study published today on bmj.com. Cancer experts are now calling for cytological smears to be offered at regular intervals for at least 25 years after a woman has had severe dysplasia/CIS (carcinoma in situ).

MRSA :: MRSA screening essential to stop hospital infections

Betsy McCaughey, Ph.D., Chairman of the Committee to Reduce Infection Deaths (RID) and a former Lt. Governor of New York State, is announcing a model MRSA screening bill and calling on state lawmakers to enact this lifesaving measure. In New York State, the bill will be carried by Assemblywoman Nettie Mayersohn of Flushing, New York. Illinois, Pennsylvania, and New Jersey have already enacted screening bills.